Global Genome Engineering Editing Competitive Landscape Professional Research Report 2024
Research Summary
Genome engineering editing involves the precise modification of an organism's DNA using various molecular tools and techniques. This field has rapidly advanced in recent years with the development of technologies such as CRISPR-Cas9, zinc finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs). These tools allow researchers to make targeted changes to specific genes within an organism's genome, such as inserting, deleting, or modifying DNA sequences. Genome editing has numerous applications in both research and practical settings, including gene therapy for treating genetic disorders, creating genetically modified organisms (GMOs) for agriculture, and understanding the function of genes in biological systems. The precision and efficiency of genome editing technologies have revolutionized the study of genetics and hold immense potential for addressing various challenges in medicine, agriculture, and biotechnology. However, ethical considerations and potential unintended consequences must be carefully considered when using genome engineering editing techniques.
According to DIResearch's in-depth investigation and research, the global Genome Engineering Editing market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Genome Engineering Editing include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Genome Engineering Editing. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Genome Engineering Editing market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Genome Engineering Editing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Genome Engineering Editing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Genome Engineering Editing Include:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Genome Engineering Editing Product Segment Include:
Homologous Recombination
Meganuclease
Genome Engineering Editing Product Application Include:
Agriculture
Medical
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Genome Engineering Editing Industry PESTEL Analysis
Chapter 3: Global Genome Engineering Editing Industry Porter’s Five Forces Analysis
Chapter 4: Global Genome Engineering Editing Major Regional Market Size and Forecast Analysis
Chapter 5: Global Genome Engineering Editing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Genome Engineering Editing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Genome Engineering Editing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources